文献速递瓣膜外科

机器人辅助房颤外科消融联合二尖瓣手术的早晚期结局

Robotic-Assisted Surgical Ablation of Atrial Fibrillation Combined With Mitral Valve Surgery.
PubMed 文献 · Ann Thorac Surg · 2018-10-11

该单中心回顾性队列纳入2007至2017年94例在机器人辅助二尖瓣手术中接受氩基柔性冷冻消融的房颤患者,多数为持续性或长程持续性房颤。研究显示无早期死亡,主要早期并发症为神经系统损伤和低心输出量综合征各2例,中位随访49.6个月房颤复发率低、5年生存率大于96%。

要点

  • 机器人辅助二尖瓣手术同期房颤冷冻消融未见早期死亡,主要早期并发症各2例。
  • 随访中位49.6个月,1年房颤复发2.2%、5年6.7%,5年生存率大于96%。
  • 术后90天空白期内早期房颤14例(14.9%),无需永久起搏器植入。

核心结论

  • 机器人辅助下二尖瓣手术同期行房颤外科消融显示出良好的安全性和有利的长期临床结局。

研究设计与样本

  • 2007至2017年单中心纳入94例(年龄53.9±12.7岁,男67例)在机器人辅助二尖瓣手术中经氩基柔性冷冻消融系统行房颤消融的患者。
  • 持续性房颤34例(36.2%),长程持续性房颤38例(40.4%)。
  • 单纯二尖瓣修复58例,单纯二尖瓣置换2例,二尖瓣联合三尖瓣修复34例。

主要发现

  • 体外循环时间222.7±57.8分钟,主动脉阻断时间134.1±30.4分钟。
  • 无早期死亡;神经系统损伤2例(2.1%),低心输出量综合征2例(2.1%);无患者需永久起搏器植入。
  • 消融后90天空白期内早期房颤14例(14.9%)。
  • 中位随访49.6个月(四分位1至3:17.2至79.4个月,完整率95.7%),晚期死亡2例(0.49%/患者年),卒中1例(0.25%/患者年);5年生存率大于96%;房颤复发1年2.2%、5年6.7%。

临床怎么用

  • 对合并持续性或长程持续性房颤、拟行机器人辅助二尖瓣手术的患者,可考虑同期行冷冻消融,需注意术后90天空白期内的早期房颤。

局限性

  • 单中心回顾性研究,样本量94例,随访心电图数据部分缺失,结果需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data on robotic-assisted surgical atrial fibrillation (AF) ablation in patients undergoing mitral valve (MV) operations are lacking. This study aimed to evaluate early and late outcomes after robotic-assisted ablation of AF combined with MV surgery. METHODS: Between 2007 and 2017, this study enrolled 94 patients (age: 53.9 ± 12.7 years; 67 men) undergoing AF ablation by using an argon-based flexible cryoablation system during robotic-assisted MV surgical procedures. Persistent (n = 34, 36.2%) or long-standing persistent (n = 38, 40.4%) AF was present in most patients. Primary valve procedures included isolated mitral repair in 58 patients, isolate mitral replacement in 2 patients, and combined mitral and tricuspid repair in 34 patients. RESULTS: Sixty patients (63.8%) received left-side-only AF ablation, whereas the others (n = 34, 36.2%) received biatrial ablation. The operation times for cardiopulmonary bypass and aortic cross-clamping were 222.7 ± 57.8 minutes and 134.1 ± 30.4 minutes, respectively. No early death was seen. Major early complications included neurologic injury in 2 patients (2.1%) and low cardiac output syndrome in 2 patients (2.1%). No patients required permanent pacemaker implantation. Early AF occurred in 14 patients (14.9%) during a postablation blanking period (90 days). During a median follow-up of 49.6 months (quartiles 1 to 3: 17.2 to 79.4 months, 95.7% complete), there were two late deaths (0.49% per patient-year) and one stroke (0.25% per patient-year). Five-year survival was greater than 96%, and results from largely electrocardiograms showed a low recurrence of AF (2.2% at 1 year, 6.7% at 5 years). CONCLUSIONS: Surgical AF ablation with the use of robotic-assistance in the setting of mitral valve surgery showed excellent safety and favorable long-term clinical outcomes.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ju MH, Huh JH, Lee CH, et al. Robotic-Assisted Surgical Ablation of Atrial Fibrillation Combined With Mitral Valve Surgery. Ann Thorac Surg. 2018. PMID: 30316854. doi:10.1016/j.athoracsur.2018.08.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。